<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The balance between proliferation and <z:mpath ids='MPATH_3'>apoptosis</z:mpath> within a tissue is important in controlling its overall growth </plain></SENT>
<SENT sid="1" pm="."><plain>When either or both are altered, uncontrolled cell proliferation can contribute to <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>The aim of this study was to investigate <z:mpath ids='MPATH_3'>apoptosis</z:mpath> and proliferation in the progression from <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> to <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> </plain></SENT>
<SENT sid="3" pm="."><plain>Fifty-one paraffin sections of Barrett's mucosa with both intestinal and gastric-type Barrett's mucosa, <z:mpath ids='MPATH_589'>dysplasia</z:mpath>, and <z:mp ids='MP_0009308'>adenocarcinoma</z:mp>, from 28 patients, were examined for <z:mpath ids='MPATH_3'>apoptosis</z:mpath> using <z:chebi fb="1" ids="51686">haematoxylin</z:chebi> and eosin (H&amp;E)-stained sections counterstained immunohistochemically with CD45 to distinguish leucocytes from apoptotic bodies </plain></SENT>
<SENT sid="4" pm="."><plain>Proliferation was detected by immunohistochemistry using the MIB-1 (Ki-67) antibody </plain></SENT>
<SENT sid="5" pm="."><plain>There was an increase in proliferation in dysplastic and carcinomatous tissue compared with <z:mpath ids='MPATH_605'>metaplastic tissue</z:mpath> (p=0.0001) </plain></SENT>
<SENT sid="6" pm="."><plain>In <z:mpath ids='MPATH_589'>dysplasia</z:mpath>, proliferation was distributed throughout the basal-<z:chebi fb="2" ids="8069">luminal</z:chebi> axis, whereas in <z:mpath ids='MPATH_160'>metaplasia</z:mpath>, cell division was compartmentalized to the lower crypt (p&lt;0.001) </plain></SENT>
<SENT sid="7" pm="."><plain>Conversely, there was a decrease in <z:mpath ids='MPATH_3'>apoptosis</z:mpath> in the upper crypt and <z:chebi fb="2" ids="8069">luminal</z:chebi> surface in <z:mpath ids='MPATH_589'>dysplasia</z:mpath> and <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> compared with <z:mpath ids='MPATH_160'>metaplasia</z:mpath> (p&lt;0.0008) </plain></SENT>
<SENT sid="8" pm="."><plain>There was a significant increase in apoptotic activity in intestinal-type Barrett's mucosa compared with gastric-type </plain></SENT>
<SENT sid="9" pm="."><plain>There was a highly significant increase in the glandular proliferation to <z:mpath ids='MPATH_3'>apoptosis</z:mpath> ratio (GPAR) in the progression of <z:mpath ids='MPATH_160'>metaplasia</z:mpath> to <z:mpath ids='MPATH_589'>dysplasia</z:mpath> to <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> (p=0.001) </plain></SENT>
<SENT sid="10" pm="."><plain>The shift in the GPAR in the progression of neoplastic change suggests that it may be a useful and sensitive marker of neoplastic change in <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e>, especially if the assessment of both apoptotic and proliferative activity in the mucosa can be made easier by more sophisticated technical methods </plain></SENT>
</text></document>